Abiopharma

🔍 Duchscher Robert (Executive)

Company: SunOpta Inc. (STKL)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 5,013 shares of Common Shares (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 23,714.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,467 shares of Common Shares at $6.49 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 21,247.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 5,013 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,012.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
• F2: This line item reflects the deemed disposition of shares withheld by the Company to satisfy income tax withholding requirements in connection with the vesting of the RSUs.
• F3: The Restricted Stock Units vest in three equal annual installments beginning on April 1, 2025 subject to the continued employment of the reporting person through each such vesting date.
• F4: The Restricted Stock Units do not have an expiration date.